WHO WE ARE
INSIGHTEC is a global team united by a common vision to transform healthcare by making MR-guided focused ultrasound a standard of care. INSIGHTEC’s MR-guided focused ultrasound technology is a game-changing innovation that allows performing surgical procedures with surgical precision but without incisions. The company’s non-invasive therapy platforms, Exablate and Exablate Neuro, are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and uterine fibroids. The company is dedicated to improving patient lives by collaborating with physicians, medical institutions, academic researchers and regulatory bodies around the world. INSIGHTEC is continuously investing in and expanding its current and investigational applications, ranging from neurosurgery to oncology and women’s health.
THE FUTURE OF MEDICINE STARTS HERE
INSIGHTEC was founded by individuals passionate about developing a breakthrough medical technology that would make a real impact on the lives of millions of people, globally. Today, INSIGHTEC remains passionate about making MR-guided focused ultrasound a standard of care. We are constantly looking into the future - expanding our research to address conditions. Our team is comprised of experts in their field, in medicine, engineering, business, marketing, or software development - people who share the INSIGHTEC vision of treating millions of patients with no incisions or scars, low to no hospitalization, rapid recovery and minimal complications.
Awards & Recognitions
Forbes: Voted One of the 10 Innovative Companies to Watch for In 2016
The INSIGHTEC Exablate procedure uses guided ultrasound and MRI to enable doctors to treat essential tremor, tremor dominant parkinsons disease, bone metastasis and symptomatic uterine fibroids without performing any surgery. If widely adopted, the technology could reduce the need for surgery for many patients around the globe.
INSIGHTEC was included in the World Medical Innovation Forum’s “Disruptive Dozen” list
This prestigious list recognizes the 12 emerging technologies with the potential to revolutionize neurological and psychiatric care over the next decade. Specifically, INSIGHTEC was recognized for its Neurology solution, combining transcranial MRI-guided focused ultrasound and focused ultrasound with microbubbles that allow physicians to target tissues deep within the body through the use of sound waves, as opposed to incisions and radiation. Focused ultrasound has the ability to revolutionize the treatment of conditions such as brain cancer and Alzheimer’s through its potential for greater precision and quicker patient recovery.
TIME magazine has named MR guided Focused Ultrasound (Exablate MRgFUS) as one of the 50 best inventions of the year.
Time Magazine Award - The report, which appeared in the magazine’s Novmber 28, 2011 “invention” issue, states: “Magnetic-resonance-imaging (MRI) and ultrasound technologies are each remarkable in their own right, but combine them and you get something life-changing. A technique called focused ultrasound uses MRI pictures to guide multiple beams of acoustic energy into concentrated hot spot deep inside the body to heat and melt away tumors or other growths like uterine fibroids. A version of the device is being tested to tweak brain regions to relieve pain and even tremors associated with Parkinson’s.”
The World Economic Forum has selected INSIGHTEC as one of its Technology Pioneers for 2008
Technology Pioneers are companies developing and applying technologies deemed highly transformational and innovative in the areas of energy, biotechnology and health and information technology.
The World Economic Forum appointed a panel of leading technology experts to select finalists from a pool of 273 nominees. INSIGHTEC’s vision is to develop next generation, non-invasive, outpatient operating room that minimizes trauma, morbidity and recovery time. The company’s Exablate® 2000 is the world’s first and only non-invasive surgery system to combine focused ultrasound and magnetic resonance imaging.
Red Herring 100 Europe 2007 Award
Red Herring magazine has named INSIGHTEC to its Red Herring 100 Europe 2007 list of the top privately-held technology companies in Europe, the Middle East and Africa (EMEA). Red Herring lists of top private companies are an important part of the company’s tradition of identifying new and innovative technology companies and entrepreneurs. Companies like Google, eBay and Skype were spotted in their early days by Red Herring editors, and touted as leaders that would change the way we live and work. Red Herring editorial staff rigorously evaluates entrepreneurial companies in a careful analysis of financial data and subjective criteria, including quality of management, execution of strategy, and dedication to research and development.
INSIGHTEC was the winner of Frost and Sullivan’s 2005 Technical Innovation Award
INSIGHTEC was the winner of Frost and Sullivan’s 2005 Technical Innovation Award in the field of non-invasive medical devices for outstanding industry achievement. Frost & Sullivan, the international growth consulting firm, recognized INSIGHTEC as its Exablate® 2000 was the first U.S. Food and Drug Administration (FDA) approved Magnetic Resonance-guided Focused Ultrasound (Exablate MRgFUS) technology for the non-invasive treatment of uterine fibroids.
INSIGHTEC’s Exablate was awarded the Wall St. Journal's 2004 bronze prize for Technology innovation
The award recognizes technological breakthroughs by individuals, companies and organizations around the world in a wide range of areas, including medicine, software, hardware, the Internet, wireless and broadcasting. “Through these awards, The Wall Street Journal seeks to recognize innovation—and each of these winners embodies the creative thinking that enabled them to rise the top of their respective industries,” said Karen Elliott House, publisher, The Wall Street Journal, and senior vice president, Dow Jones & Company. “We also believe that in today’s business environment, it has never been more important to discover and nurture new ideas".